John Northcott, SVP & Chief Commercial Officer at NEKTAR THERAPEUTICS (NKTR), sold 9,704 shares at $10.95 ($106K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Open-market sale of $106k NKTR by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.95 | 4,852 | $53K | 50.0% |
| 2 | $10.95 | 4,852 | $53K | 50.0% |
| Total | $10.95 avg | 9,704 | $106K | 100% |
| Filing → |
| NKTR | SELL | 2021-08-18 | $171K | — | Filing → |
| NKTR | SELL | 2021-05-19 | $223K | — | Filing → |
| NKTR | SELL | 2021-02-18 | $687K | — | Filing → |